Pharmaceutical-grade research supply
Tirzepatide
30 mg • GLP-1 / GIP
Dual GIP/GLP-1 receptor agonist.
Dual GIP and GLP-1 receptor agonist synthesized to research-grade purity — 30 mg per vial, HPLC-verified and mass-spec confirmed. For laboratory research use only.
Shopify button not yet configured for this product.
Admin: paste the Shopify Buy Button embed code in the product editor.
Key research benefits
- Dual GIP + GLP-1 receptor agonism
- 30 mg lyophilized per vial
- HPLC-verified purity ≥99.5%
- Third-party mass-spec identity confirmation
- Full chain-of-custody documentation
Specifications
Details
Tirzepatide (research code LY3298176) is a single-molecule dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Widely used in metabolic, endocrine, and translational research studies.
Each vial contains 30 mg of lyophilized tirzepatide sealed under inert atmosphere. Every lot is HPLC-purity tested and mass-spec identity confirmed by an independent third-party laboratory, with a lot-specific Certificate of Analysis available on request.
For research and licensed clinical use only. Not for human consumption unless prescribed by a licensed medical professional.
Frequently asked questions
Related research supplies
For research use only. Not for human consumption or therapeutic use. All products are intended solely for in-vitro laboratory research and are not to be used for diagnostic or therapeutic purposes.